These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 25851408)

  • 1. Furan-based benzene mono- and dicarboxylic acid derivatives as multiple inhibitors of the bacterial Mur ligases (MurC-MurF): experimental and computational characterization.
    Perdih A; Hrast M; Pureber K; Barreteau H; Grdadolnik SG; Kocjan D; Gobec S; Solmajer T; Wolber G
    J Comput Aided Mol Des; 2015 Jun; 29(6):541-60. PubMed ID: 25851408
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benzene-1,3-dicarboxylic acid 2,5-dimethylpyrrole derivatives as multiple inhibitors of bacterial Mur ligases (MurC-MurF).
    Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
    Bioorg Med Chem; 2014 Aug; 22(15):4124-34. PubMed ID: 24953950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of the published kinase inhibitor set to identify multiple inhibitors of bacterial ATP-dependent mur ligases.
    Hrast M; Rožman K; Ogris I; Škedelj V; Patin D; Sova M; Barreteau H; Gobec S; Grdadolnik SG; Zega A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1010-1017. PubMed ID: 31072165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and biological evaluation of N-acylhydrazones as inhibitors of MurC and MurD ligases.
    Sink R; Kovac A; Tomasić T; Rupnik V; Boniface A; Bostock J; Chopra I; Blanot D; Masic LP; Gobec S; Zega A
    ChemMedChem; 2008 Sep; 3(9):1362-70. PubMed ID: 18651694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibitor design strategy based on an enzyme structural flexibility: a case of bacterial MurD ligase.
    Perdih A; Hrast M; Barreteau H; Gobec S; Wolber G; Solmajer T
    J Chem Inf Model; 2014 May; 54(5):1451-66. PubMed ID: 24724969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of new inhibitors of the bacterial peptidoglycan biosynthesis enzymes MurD and MurF by structure-based virtual screening.
    Turk S; Kovac A; Boniface A; Bostock JM; Chopra I; Blanot D; Gobec S
    Bioorg Med Chem; 2009 Mar; 17(5):1884-9. PubMed ID: 19223185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening for potential inhibitors of bacterial MurC and MurD ligases.
    Tomašić T; Kovač A; Klebe G; Blanot D; Gobec S; Kikelj D; Mašič LP
    J Mol Model; 2012 Mar; 18(3):1063-72. PubMed ID: 21667288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-activity relationships of new cyanothiophene inhibitors of the essential peptidoglycan biosynthesis enzyme MurF.
    Hrast M; Turk S; Sosič I; Knez D; Randall CP; Barreteau H; Contreras-Martel C; Dessen A; O'Neill AJ; Mengin-Lecreulx D; Blanot D; Gobec S
    Eur J Med Chem; 2013 Aug; 66():32-45. PubMed ID: 23786712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery of novel benzene 1,3-dicarboxylic acid inhibitors of bacterial MurD and MurE ligases by structure-based virtual screening approach.
    Perdih A; Kovac A; Wolber G; Blanot D; Gobec S; Solmajer T
    Bioorg Med Chem Lett; 2009 May; 19(10):2668-73. PubMed ID: 19369074
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of Ideal Multi-targeting Bioactive Compounds Against Mur Ligases of Enterobacter aerogenes and Its Binding Mechanism in Comparison with Chemical Inhibitors.
    Chakkyarath V; Natarajan J
    Interdiscip Sci; 2019 Mar; 11(1):135-144. PubMed ID: 29086207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated hydroxyethylamines as novel inhibitors of the bacterial cell wall biosynthesis enzymes MurC to MurF.
    Sova M; Kovac A; Turk S; Hrast M; Blanot D; Gobec S
    Bioorg Chem; 2009 Dec; 37(6):217-22. PubMed ID: 19804894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 5-Benzylidenethiazolidin-4-ones as multitarget inhibitors of bacterial Mur ligases.
    Tomasić T; Zidar N; Kovac A; Turk S; Simcic M; Blanot D; Müller-Premru M; Filipic M; Grdadolnik SG; Zega A; Anderluh M; Gobec S; Kikelj D; Peterlin Masic L
    ChemMedChem; 2010 Feb; 5(2):286-95. PubMed ID: 20024979
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mur ligases inhibitors with azastilbene scaffold: Expanding the structure-activity relationship.
    Hrast M; Frlan R; Knez D; Zdovc I; Barreteau H; Gobec S
    Bioorg Med Chem Lett; 2021 May; 40():127966. PubMed ID: 33744441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mur Ligase Inhibitors as Anti-bacterials: A Comprehensive Review.
    Sangshetti JN; Joshi SS; Patil RH; Moloney MG; Shinde DB
    Curr Pharm Des; 2017; 23(21):3164-3196. PubMed ID: 28201974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural and functional characterization of enantiomeric glutamic acid derivatives as potential transition state analogue inhibitors of MurD ligase.
    Kotnik M; Humljan J; Contreras-Martel C; Oblak M; Kristan K; Hervé M; Blanot D; Urleb U; Gobec S; Dessen A; Solmajer T
    J Mol Biol; 2007 Jun; 370(1):107-15. PubMed ID: 17507028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel 2-oxoindolinylidene inhibitor of bacterial MurD ligase: Enzyme kinetics, protein-inhibitor binding by NMR and a molecular dynamics study.
    Simčič M; Pureber K; Kristan K; Urleb U; Kocjan D; Grdadolnik SG
    Eur J Med Chem; 2014 Aug; 83():92-101. PubMed ID: 24952377
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel naphthalene-N-sulfonyl-D-glutamic acid derivatives as inhibitors of MurD, a key peptidoglycan biosynthesis enzyme.
    Humljan J; Kotnik M; Contreras-Martel C; Blanot D; Urleb U; Dessen A; Solmajer T; Gobec S
    J Med Chem; 2008 Dec; 51(23):7486-94. PubMed ID: 19007109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MurD enzymes: some recent developments.
    Šink R; Barreteau H; Patin D; Mengin-Lecreulx D; Gobec S; Blanot D
    Biomol Concepts; 2013 Dec; 4(6):539-56. PubMed ID: 25436755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The biology of Mur ligases as an antibacterial target.
    Kouidmi I; Levesque RC; Paradis-Bleau C
    Mol Microbiol; 2014 Oct; 94(2):242-53. PubMed ID: 25130693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of Antibacterial Compounds with Potential Multi-Pharmacology against Staphylococcus
    Teshima M; Monobe K; Okubo S; Aoki S
    Molecules; 2024 Aug; 29(16):. PubMed ID: 39202871
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.